Product Information

DEXTROAMP-AMPHETAMIN 30 MG TAB is a generic product labeled by Sunrise Pharmaceutical Inc., priced at $0.3048 per EA under NDC 11534019601. Its NADAC has been published 303 times since Sep 9, 2020.

DEA Schedule CII

Strength

7.5; 7.5; 7.5; 7.5 mg/1; mg/1; mg/1; mg/1

NDC

11534019601

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA209799

On Market Since

7/4/2018

Pharmacological Classes

Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulant
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation
Central Nervous System Stimulation

Price Statistics

The NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has been published 303 times since Sep 9, 2020, and over the history we have for it it has declined 21.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3048 per EA
All-time high$0.4212 (Dec 16, 2020)
All-time low$0.2416 (Jul 17, 2024)
52-week high$0.3373
52-week low$0.3037
Median price$0.3169
Average price$0.3258
Largest weekly change-26.9% (Nov 20, 2024)
Weeks tracked303
Tracking sinceSep 9, 2020

Price History

1W

0.0%

1M

-0.3%

3M

-2.8%

6M

-2.4%

1Y

-9.6%

3Y

-6.1%

5Y

-15.0%

All

-21.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of DEXTROAMP-AMPHETAMIN 30 MG TAB?

The current National Average Drug Acquisition Cost (NADAC) for DEXTROAMP-AMPHETAMIN 30 MG TAB, manufactured by Sunrise Pharmaceutical Inc., is $0.3048 per EA (NDC 11534019601), effective Jun 24, 2026.

How has the price of DEXTROAMP-AMPHETAMIN 30 MG TAB changed over time?

Over the history we have for it, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has declined 21.2%. It has been tracked across 303 weekly CMS publications since Sep 9, 2020.

What are the highest and lowest recorded NADAC prices for DEXTROAMP-AMPHETAMIN 30 MG TAB?

Since Sep 9, 2020, the NADAC for DEXTROAMP-AMPHETAMIN 30 MG TAB has ranged from a low of $0.2416 (Jul 17, 2024) to a high of $0.4212 (Dec 16, 2020), with a median of $0.3169 per EA.

Are there cheaper alternatives to DEXTROAMP-AMPHETAMIN 30 MG TAB?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of DEXTROAMP-AMPHETAMIN 30 MG TAB, so no direct lower-cost alternative is listed.

Who manufactures DEXTROAMP-AMPHETAMIN 30 MG TAB?

DEXTROAMP-AMPHETAMIN 30 MG TAB (NDC 11534019601) is labeled by Sunrise Pharmaceutical Inc., and CMS classifies it as a generic product.